LSA
GSK icon

Leonteq Securities AG’s GSK GSK Stock Holding History

Leonteq Securities AG’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51K Hold
86
– – ﹤0.01% 1099
2026
Q1 		$4.75K Sell
86
-292
-77% -$15.8K ﹤0.01% 1127
2025
Q4 		$18.5K Sell
378
-289
-43% -$13.5K ﹤0.01% 1110
2025
Q3 		$28.8K Buy
667
+330
+98% +$12.9K ﹤0.01% 980
2025
Q2 		$12.9K Sell
337
-761
-69% -$29.1K ﹤0.01% 1031
2025
Q1 		$42.6K Sell
1,098
-2,334
-68% -$85.4K ﹤0.01% 853
2024
Q4 		$116K Buy
3,432
+1,519
+79% +$54.7K 0.01% 655
2024
Q3 		$78.2K Buy
1,913
+662
+53% +$27.1K 0.01% 671
2024
Q2 		$48.2K Buy
1,251
+822
+192% +$34.6K ﹤0.01% 774
2024
Q1 		$18.4K Sell
429
-239
-36% -$9.86K ﹤0.01% 939
2023
Q4 		$24.8K Sell
668
-49
-7% -$1.76K ﹤0.01% 910
2023
Q3 		$26K Sell
717
-2,093
-74% -$74.3K ﹤0.01% 917
2023
Q2 		$100K Buy
+2,810
New +$101K 0.01% 673

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Leonteq Securities AG's GSK Position: Q2 2026 in Review

Leonteq Securities AG held its GSK (GSK) position steady in Q2 2026 at 86 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Leonteq Securities AG first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $116K in Q4 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Leonteq Securities AG held 86 shares of GSK worth $4.51K as of Q2 2026.
  • Leonteq Securities AG left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1099 holding.
  • Leonteq Securities AG first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
  • Leonteq Securities AG's GSK position peaked at $116K in Q4 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.